Janux Therapeutics (JANX)
(Delayed Data from NSDQ)
$42.28 USD
+0.73 (1.76%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $42.25 -0.03 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
JANX 42.28 +0.73(1.76%)
Will JANX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for JANX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for JANX
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates
Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
JANX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors
Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable
Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet
Other News for JANX
Janux Therapeutics: Promising T-Cell Engager Platform In Cancer Therapy
Small-cap, buy-rated stocks with positive estimate revision factors - BofA
Wall Street Analysts Are Bullish on Top Healthcare Picks
Ambarella Posts Upbeat Results, Joins Gap, PagerDuty, Elastic And Other Big Stocks Moving Higher On Friday
Janux Therapeutics participates in a conference call with Cantor Fitzgerald